Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Renal Failure

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 146 articles:
HTML format
Text format



Single Articles


    June 2017
  1. MARSHALL MR
    Measuring the patient response to dialysis therapy: hemodiafiltration and clinical trials.
    Kidney Int. 2017;91:1279-1282.
    PubMed     Text format     Abstract available


  2. CLAYTON PA, Coates PT
    Are sensitized patients better off with a desensitization transplant or waiting on dialysis?
    Kidney Int. 2017;91:1266-1268.
    PubMed     Text format     Abstract available


  3. ZHANG G, Saito R, Sharma K
    A metabolite-GWAS (mGWAS) approach to unveil chronic kidney disease progression.
    Kidney Int. 2017;91:1274-1276.
    PubMed     Text format     Abstract available


    May 2017
  4. LIU X, Yu R, Sun L, Garibotto G, et al
    The nuclear phosphatase SCP4 regulates FoxO transcription factors during muscle wasting in chronic kidney disease.
    Kidney Int. 2017 May 12. pii: S0085-2538(17)30171.
    PubMed     Text format     Abstract available


  5. SUCCAR L, Pianta TJ, Davidson T, Pickering JW, et al
    Subclinical chronic kidney disease modifies the diagnosis of experimental acute kidney injury.
    Kidney Int. 2017 May 2. pii: S0085-2538(17)30170.
    PubMed     Text format     Abstract available


  6. KORATALA A, Chornyy V, Shukla AM, Kazory A, et al
    Tunneled dialysis catheters might receive "permanent resident" status after a while: a case for caution.
    Kidney Int. 2017;91:1259.
    PubMed     Text format    


  7. MJOEN G, Holdaas H
    Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors".
    Kidney Int. 2017;91:1256.
    PubMed     Text format    


  8. DAVENPORT A
    More frequent hemodialysis does not effectively clear protein-bound azotemic solutes derived from gut microbiome metabolism.
    Kidney Int. 2017;91:1008-1010.
    PubMed     Text format     Abstract available


  9. HAAS M
    Simultaneous liver-kidney transplantation: shifting renal allograft gene expression from inflammation toward preservation.
    Kidney Int. 2017;91:1010-1013.
    PubMed     Text format     Abstract available


    April 2017
  10. FERGUSON TW, Tangri N, Tan Z, James MT, et al
    Screening for chronic kidney disease in Canadian indigenous peoples is cost-effective.
    Kidney Int. 2017 Apr 19. pii: S0085-2538(17)30156.
    PubMed     Text format     Abstract available


  11. LIN W, Zhang Q, Liu L, Yin S, et al
    Klotho restoration via acetylation of Peroxisome Proliferation-Activated Receptor gamma reduces the progression of chronic kidney disease.
    Kidney Int. 2017 Apr 14. pii: S0085-2538(17)30158.
    PubMed     Text format     Abstract available


  12. ILIUTA IA, Lachance P, Ghannoum M, Begin Y, et al
    Prediction and validation of the duration of hemodialysis sessions for the treatment of acute ethylene glycol poisoning.
    Kidney Int. 2017 Apr 12. pii: S0085-2538(17)30151.
    PubMed     Text format     Abstract available


  13. MADSEN NL, Goldstein SL, Froslev T, Christiansen CF, et al
    Cardiac surgery in patients with congenital heart disease is associated with acute kidney injury and the risk of chronic kidney disease.
    Kidney Int. 2017 Apr 12. pii: S0085-2538(17)30155.
    PubMed     Text format     Abstract available


  14. HOSHINO J, Larkina M, Karaboyas A, Bieber BA, et al
    Unique hemoglobin A1c level distribution and its relationship with mortality in diabetic hemodialysis patients.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30110.
    PubMed     Text format     Abstract available


  15. SCHAUERTE C, Hubner A, Rong S, Wang S, et al
    Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30117.
    PubMed     Text format     Abstract available


  16. LAW BM, Wilkinson R, Wang X, Kildey K, et al
    Interferon-gamma production by tubulointerstitial human CD56bright natural killer cells contributes to renal fibrosis and chronic kidney disease progression.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30107.
    PubMed     Text format     Abstract available


  17. YAMANOUCHI M, Skupien J, Niewczas MA, Smiles AM, et al
    Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Kidney Int. 2017 Apr 7. pii: S0085-2538(17)30112.
    PubMed     Text format     Abstract available


  18. LI L, Lai EY, Luo Z, Solis G, et al
    Superoxide and hydrogen peroxide counterregulate myogenic contractions in renal afferent arterioles from a mouse model of chronic kidney disease.
    Kidney Int. 2017 Apr 7. pii: S0085-2538(17)30111.
    PubMed     Text format     Abstract available


  19. VERMA S, Bassily E, Jarmi T
    An extreme case of tumoral calcinosis in an end-stage renal disease patient.
    Kidney Int. 2017;91:991.
    PubMed     Text format    


  20. IYASERE O, Brown EA
    Cognitive function before and after dialysis initiation in adults with chronic kidney disease-a new perspective on an old problem?
    Kidney Int. 2017;91:784-786.
    PubMed     Text format     Abstract available


  21. WYATT CM
    Decreased incidence of end-stage renal disease in American Indians with diabetes: a model for other high-risk populations?
    Kidney Int. 2017;91:766-768.
    PubMed     Text format     Abstract available


  22. HEINE GH, Brandenburg V
    Anticoagulation, atrial fibrillation, and chronic kidney disease-whose side are you on?
    Kidney Int. 2017;91:778-780.
    PubMed     Text format     Abstract available


    March 2017
  23. KROLEWSKI AS, Skupien J, Rossing P, Warram JH, et al
    Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30081.
    PubMed     Text format     Abstract available


  24. LAM NN, Tonelli M, Lentine KL, Hemmelgarn B, et al
    Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30093.
    PubMed     Text format     Abstract available


  25. BRASEN JH, Khalifa A, Schmitz J, Dai W, et al
    Macrophage density in early surveillance biopsies predicts future renal transplant function.
    Kidney Int. 2017 Mar 27. pii: S0085-2538(17)30094.
    PubMed     Text format     Abstract available


  26. KITTISKULNAM P, Chertow GM, Carrero JJ, Delgado C, et al
    Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis.
    Kidney Int. 2017 Mar 16. pii: S0085-2538(17)30082.
    PubMed     Text format     Abstract available


  27. ZHANG J, Friberg IM, Kift-Morgan A, Parekh G, et al
    Machine-learning algorithms define pathogen-specific local immune fingerprints in peritoneal dialysis patients with bacterial infections.
    Kidney Int. 2017 Mar 16. pii: S0085-2538(17)30068.
    PubMed     Text format     Abstract available


  28. ALTMANN C, Ahuja N, Kiekhaefer CM, Andres Hernando A, et al
    Early peritoneal dialysis reduces lung inflammation in mice with ischemic acute kidney injury.
    Kidney Int. 2017 Mar 16. pii: S0085-2538(17)30071.
    PubMed     Text format     Abstract available


  29. MORENA M, Jaussent A, Chalabi L, Leray-Moragues H, et al
    Treatment tolerance and patient-reported outcomes favor online hemodiafiltration compared to high-flux hemodialysis in the elderly.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30040.
    PubMed     Text format     Abstract available


  30. GRACIOLLI FG, Neves KR, Barreto F, Barreto DV, et al
    The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30025.
    PubMed     Text format     Abstract available


  31. SICARD A, Meas-Yedid V, Rabeyrin M, Koenig A, et al
    Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30038.
    PubMed     Text format     Abstract available


  32. MCMAHON GM, Hwang SJ, Clish CB, Tin A, et al
    Urinary metabolites along with common and rare genetic variations are associated with incident chronic kidney disease.
    Kidney Int. 2017 Mar 14. pii: S0085-2538(17)30034.
    PubMed     Text format     Abstract available


  33. PORT FK, Robinson BM, McCullough KP, Morgenstern H, et al
    Predialysis blood pressure on survival in hemodialysis patients.
    Kidney Int. 2017;91:755-756.
    PubMed     Text format    



  34. Charytan DM, Desai M, Mathur M, et al. Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease. Kidney Int. 2016;90:411
    Kidney Int. 2017;91:758.
    PubMed     Text format    


  35. OHNO Y, Kanno Y, Takenaka T
    Letter regarding "Estimated aortic blood pressure based on radial artery tonometry underestimates directly measured aortic blood pressure in patients with advancing chronic kidney disease staging and increasing arterial stiffness".
    Kidney Int. 2017;91:757.
    PubMed     Text format    


    February 2017
  36. BAGSHAW SM, Wald R
    Strategies for the optimal timing to start renal replacement therapy in critically ill patients with acute kidney injury.
    Kidney Int. 2017 Feb 17. pii: S0085-2538(16)30755.
    PubMed     Text format     Abstract available


  37. XING YF, Cai RM, Lin Q, Ye QJ, et al
    Expansion of polymorphonuclear myeloid-derived suppressor cells in patients with end-stage renal disease may lead to infectious complications.
    Kidney Int. 2017 Feb 16. pii: S0085-2538(16)30756.
    PubMed     Text format     Abstract available


  38. DEKKER MJ, Marcelli D, Canaud BJ, Carioni P, et al
    Impact of fluid status and inflammation and their interaction on survival: a study in an international hemodialysis patient cohort.
    Kidney Int. 2017 Feb 13. pii: S0085-2538(16)30710.
    PubMed     Text format     Abstract available


  39. WEBSTER P, Lightstone L, McKay DB, Josephson MA, et al
    Pregnancy in chronic kidney disease and kidney transplantation.
    Kidney Int. 2017 Feb 13. pii: S0085-2538(16)30748.
    PubMed     Text format     Abstract available


  40. GAROFALO C, Borrelli S, Minutolo R, Chiodini P, et al
    A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population.
    Kidney Int. 2017 Feb 7. pii: S0085-2538(16)30752.
    PubMed     Text format     Abstract available


  41. AL AZZI Y, Daleo J, Dube G
    To Be or not To Be: a rare cause of AKI in a renal allograft.
    Kidney Int. 2017;91:513.
    PubMed     Text format    


    January 2017
  42. KURELLA TAMURA M, Vittinghoff E, Hsu CY, Tam K, et al
    Loss of executive function after dialysis initiation in adults with chronic kidney disease.
    Kidney Int. 2017 Jan 27. pii: S0085-2538(16)30701.
    PubMed     Text format     Abstract available


  43. HU MC, Shi M, Gillings N, Flores B, et al
    Recombinant alpha-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Kidney Int. 2017 Jan 25. pii: S0085-2538(16)30649.
    PubMed     Text format     Abstract available


  44. HAAS M, Mirocha J, Reinsmoen NL, Vo AA, et al
    Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Kidney Int. 2017 Jan 16. pii: S0085-2538(16)30656.
    PubMed     Text format     Abstract available


  45. GARG AX, Suri RS, Eggers P, Finkelstein FO, et al
    Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.
    Kidney Int. 2017 Jan 13. pii: S0085-2538(16)30647.
    PubMed     Text format     Abstract available


  46. SIRICH TL, Fong K, Larive B, Beck GJ, et al
    Limited reduction in uremic solute concentrations with increased dialysis frequency and time in the Frequent Hemodialysis Network Daily Trial.
    Kidney Int. 2017 Jan 12. pii: S0085-2538(16)30648.
    PubMed     Text format     Abstract available


  47. LIAO CT, Andrews R, Wallace LE, Khan MW, et al
    Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes.
    Kidney Int. 2017 Jan 5. pii: S0085-2538(16)30640.
    PubMed     Text format     Abstract available


  48. KOBAYASHI R, Wakui H, Azushima K, Uneda K, et al
    An angiotensin II type 1 receptor binding molecule has a critical role in hypertension in a chronic kidney disease model.
    Kidney Int. 2017 Jan 4. pii: S0085-2538(16)30650.
    PubMed     Text format     Abstract available


  49. ASSIS LV, Pereira ER, Sa CB, Guimaraes-Neto I, et al
    Right ventricular perforation by tunneled hemodialysis catheter.
    Kidney Int. 2017;91:255.
    PubMed     Text format    


  50. WYATT CM
    A rose by any other name: is stage 3a chronic kidney disease really a disease?
    Kidney Int. 2017;91:6-8.
    PubMed     Text format     Abstract available


  51. CAPLIN B, Nitsch D
    Urinary biomarkers of tubular injury in chronic kidney disease.
    Kidney Int. 2017;91:21-23.
    PubMed     Text format     Abstract available


  52. HATTORI M
    Hemoglobin target in children with chronic kidney disease: valuable new information.
    Kidney Int. 2017;91:16-18.
    PubMed     Text format     Abstract available


    December 2016
  53. LOCKE JE, Reed RD, Massie A, MacLennan PA, et al
    Obesity increases the risk of end-stage renal disease among living kidney donors.
    Kidney Int. 2016 Dec 29. pii: S0085-2538(16)30613.
    PubMed     Text format     Abstract available


  54. MATHEW RO, Bangalore S, Lavelle MP, Pellikka PA, et al
    Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review.
    Kidney Int. 2016 Dec 28. pii: S0085-2538(16)30625.
    PubMed     Text format     Abstract available


  55. KESKAR V, McArthur E, Wald R, Harel Z, et al
    The association of anticoagulation, ischemic stroke, and hemorrhage in elderly adults with chronic kidney disease and atrial fibrillation.
    Kidney Int. 2016 Dec 22. pii: S0085-2538(16)30618.
    PubMed     Text format     Abstract available


  56. MUNOZ MENDOZA J, Isakova T, Cai X, Bayes LY, et al
    Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
    Kidney Int. 2016 Dec 22. pii: S0085-2538(16)30622.
    PubMed     Text format     Abstract available


  57. TRIPEPI G, Pannier B, D'Arrigo G, Mallamaci F, et al
    Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure.
    Kidney Int. 2016 Dec 20. pii: S0085-2538(16)30611.
    PubMed     Text format     Abstract available


  58. EVENEPOEL P, Behets GJ, Viaene L, D'Haese PC, et al
    Bone histomorphometry in de novo renal transplant recipients indicates a further decline in bone resorption 1 year posttransplantation.
    Kidney Int. 2016 Dec 17. pii: S0085-2538(16)30607.
    PubMed     Text format     Abstract available


  59. LITJENS NH, Boer K, Zuijderwijk JM, Klepper M, et al
    Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs.
    Kidney Int. 2016 Dec 14. pii: S0085-2538(16)30599.
    PubMed     Text format     Abstract available


  60. SOLEIMANI A, Zarrati Mojarrad M, Bahmani F, Taghizadeh M, et al
    Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects.
    Kidney Int. 2016 Dec 4. pii: S0085-2538(16)30592.
    PubMed     Text format     Abstract available


  61. CARRERO JJ, Grams ME, Sang Y, Arnlov J, et al
    Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.
    Kidney Int. 2016 Dec 4. pii: S0085-2538(16)30589.
    PubMed     Text format     Abstract available


  62. SCHELLINGER IN, Cordasic N, Panesar J, Buchholz B, et al
    Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
    Kidney Int. 2016 Dec 4. pii: S0085-2538(16)30561.
    PubMed     Text format     Abstract available


  63. KIM CS, Bae EH, Ma SK, Kim SW, et al
    The Case | Seizure, ophthalmoplegia, and amnesia in a peritoneal dialysis patient.
    Kidney Int. 2016;90:1389-1390.
    PubMed     Text format    


  64. DAVIES SJ
    Normalizing the peritoneal dialysis dose-have we got it right?
    Kidney Int. 2016;90:1162-1163.
    PubMed     Text format     Abstract available


  65. FARRINGTON K, Davenport A
    Would prescribing target Kt dose adjusted for body surface area improve hemodialysis outcomes?
    Kidney Int. 2016;90:1160-1162.
    PubMed     Text format     Abstract available


  66. WALD R, Perl J
    Extended hours hemodialysis and survival: extended hours, extended evidence?
    Kidney Int. 2016;90:1155-1157.
    PubMed     Text format     Abstract available


  67. LEE MJ, Park JT, Park KS, Kwon YE, et al
    Normal body mass index with central obesity has increased risk of coronary artery calcification in Korean patients with chronic kidney disease.
    Kidney Int. 2016;90:1368-1376.
    PubMed     Text format     Abstract available


  68. WYATT CM, Spence JD
    Folic acid supplementation and chronic kidney disease progression.
    Kidney Int. 2016;90:1144-1145.
    PubMed     Text format     Abstract available


    November 2016
  69. VERVLOET M, Cozzolino M
    Vascular calcification in chronic kidney disease: different bricks in the wall?
    Kidney Int. 2016 Nov 30. pii: S0085-2538(16)30553.
    PubMed     Text format     Abstract available


  70. TANAKA K, Watanabe T, Takeuchi A, Ohashi Y, et al
    Cardiovascular events and death in Japanese patients with chronic kidney disease.
    Kidney Int. 2016 Nov 21. pii: S0085-2538(16)30541.
    PubMed     Text format     Abstract available


  71. RHEAULT MN, Molony JT, Nevins T, Herzog CA, et al
    Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.
    Kidney Int. 2016 Nov 16. pii: S0085-2538(16)30539.
    PubMed     Text format     Abstract available


  72. WYATT CM, Drueke TB
    HIF stabilization by prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
    Kidney Int. 2016;90:923-925.
    PubMed     Text format     Abstract available


  73. ELRGGAL ME, Kotb GA, Elghitani A, Zyada R, et al
    Coronary revascularization in chronic kidney disease patients, external validity of meta-analysis results.
    Kidney Int. 2016;90:1131-1132.
    PubMed     Text format    


    October 2016
  74. HSU CY, Xie D, Waikar SS, Bonventre JV, et al
    Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
    Kidney Int. 2016 Oct 28. pii: S0085-2538(16)30486.
    PubMed     Text format     Abstract available


  75. CHERUKURI A, Salama AD, Carter CR, Landsittel D, et al
    Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function.
    Kidney Int. 2016 Oct 28. pii: S0085-2538(16)30481.
    PubMed     Text format     Abstract available


  76. MADUELL F, Ramos R, Varas J, Martin-Malo A, et al
    Hemodialysis patients receiving a greater Kt dose than recommended have reduced mortality and hospitalization risk.
    Kidney Int. 2016 Oct 22. pii: S0085-2538(16)30469.
    PubMed     Text format     Abstract available


  77. BROWN EA, Finkelstein FO, Iyasere OU, Kliger AS, et al
    Peritoneal or hemodialysis for the frail elderly patient, the choice of 2 evils?
    Kidney Int. 2016 Oct 20. pii: S0085-2538(16)30474.
    PubMed     Text format     Abstract available


  78. GEWIN L, Zent R, Pozzi A
    Progression of chronic kidney disease: too much cellular talk causes damage.
    Kidney Int. 2016 Oct 20. pii: S0085-2538(16)30473.
    PubMed     Text format     Abstract available


  79. BANSAL N, McCulloch CE, Lin F, Robinson-Cohen C, et al
    Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney disease.
    Kidney Int. 2016 Oct 4. pii: S0085-2538(16)30436.
    PubMed     Text format     Abstract available


  80. GRAHAM-BROWN MP, March DS, Churchward DR, Stensel DJ, et al
    Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients.
    Kidney Int. 2016;90:835-44.
    PubMed     Text format     Abstract available


  81. SHROFF GR, Raggi P
    Exploring the elusive link between subclinical fibrosis and clinical events in end-stage renal disease: does cardiac magnetic resonance imaging hold the key?
    Kidney Int. 2016;90:729-32.
    PubMed     Text format     Abstract available


  82. YADAV AK, Kumar V, Sinha N, Jha V, et al
    APOL1 risk allele variants are absent in Indian patients with chronic kidney disease.
    Kidney Int. 2016;90:906-7.
    PubMed     Text format    


  83. VAN EERDE AM, Krediet CT, Rookmaaker MB, van Reekum FE, et al
    Pre-pregnancy advice in chronic kidney disease: do not forget genetic counseling.
    Kidney Int. 2016;90:905-6.
    PubMed     Text format    


    September 2016
  84. TAMPE B, Steinle U, Tampe D, Carstens JL, et al
    Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
    Kidney Int. 2016 Sep 27. pii: S0085-2538(16)30428.
    PubMed     Text format     Abstract available


  85. ZHANG Q, Liu L, Lin W, Yin S, et al
    Rhein reverses Klotho repression via promoter demethylation and protects against kidney and bone injuries in mice with chronic kidney disease.
    Kidney Int. 2016 Sep 27. pii: S0085-2538(16)30426.
    PubMed     Text format     Abstract available


  86. MATSUSHITA K, Chen J, Sang Y, Ballew SH, et al
    Risk of end-stage renal disease in Japanese patients with chronic kidney disease increases proportionately to decline in estimated glomerular filtration rate.
    Kidney Int. 2016 Sep 22. pii: S0085-2538(16)30429.
    PubMed     Text format     Abstract available


  87. SUGATANI T, Agapova OA, Fang Y, Berman AG, et al
    Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.
    Kidney Int. 2016 Sep 22. pii: S0085-2538(16)30425.
    PubMed     Text format     Abstract available


  88. SOTO K, Campos P, Pinto I, Rodrigues B, et al
    The risk of chronic kidney disease and mortality are increased after community-acquired acute kidney injury.
    Kidney Int. 2016 Sep 19. pii: S0085-2538(16)30356.
    PubMed     Text format     Abstract available


  89. EL-KATEB S, Sridharan S, Farrington K, Fan S, et al
    A single weekly Kt/Vurea target for peritoneal dialysis patients does not provide an equal dialysis dose for all.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30400.
    PubMed     Text format     Abstract available


  90. AMARAL S, Sayed BA, Kutner N, Patzer RE, et al
    Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30401.
    PubMed     Text format     Abstract available


  91. EVENEPOEL P, Bover J, Torres PU
    Parathyroid hormone metabolism and signaling in health and chronic kidney disease.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30402.
    PubMed     Text format     Abstract available


  92. DONG J, Dong Y, Chen Z, Mitch WE, et al
    The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro/adipogenic progenitor cells in chronic kidney disease.
    Kidney Int. 2016 Sep 18. pii: S0085-2538(16)30404.
    PubMed     Text format     Abstract available


  93. PERGOLA PE, Spinowitz BS, Hartman CS, Maroni BJ, et al
    Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease.
    Kidney Int. 2016 Sep 17. pii: S0085-2538(16)30357.
    PubMed     Text format     Abstract available


  94. MARSHALL MR
    Observations of twice a week hemodialysis.
    Kidney Int. 2016 Sep 16. pii: S0085-2538(16)30380.
    PubMed     Text format     Abstract available


  95. HANNEDOUCHE T, Roth H, Krummel T, London GM, et al
    Multiphasic effects of blood pressure on survival in hemodialysis patients.
    Kidney Int. 2016;90:674-84.
    PubMed     Text format     Abstract available


    August 2016
  96. CHEIKH HASSAN HI, Tang M, Djurdjev O, Langsford D, et al
    Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney disease and mortality.
    Kidney Int. 2016 Aug 30. pii: S0085-2538(16)30350.
    PubMed     Text format     Abstract available


  97. KIENEKER LM, Bakker SJ, de Boer RA, Navis GJ, et al
    Low potassium excretion but not high sodium excretion is associated with increased risk of developing chronic kidney disease.
    Kidney Int. 2016 Aug 26. pii: S0085-2538(16)30349.
    PubMed     Text format     Abstract available


  98. RIVARA MB, Adams SV, Kuttykrishnan S, Kalantar-Zadeh K, et al
    Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30322.
    PubMed     Text format     Abstract available


  99. MATHEW A, Obi Y, Rhee CM, Chen JL, et al
    Treatment frequency and mortality among incident hemodialysis patients in the United States comparing incremental with standard and more frequent dialysis.
    Kidney Int. 2016 Aug 12. pii: S0085-2538(16)30299.
    PubMed     Text format     Abstract available


  100. CEJKA D, Parada-Rodriguez D, Pichler S, Marculescu R, et al
    Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.
    Kidney Int. 2016 Aug 12. pii: S0085-2538(16)30308.
    PubMed     Text format     Abstract available


  101. RUTHERFORD E, Talle MA, Mangion K, Bell E, et al
    Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.
    Kidney Int. 2016 Aug 5. pii: S0085-2538(16)30298.
    PubMed     Text format     Abstract available


  102. BRIER ME, Gaweda AE
    Artificial intelligence for optimal anemia management in end-stage renal disease.
    Kidney Int. 2016;90:259-61.
    PubMed     Text format     Abstract available


  103. MORADI H, Said HM
    Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients.
    Kidney Int. 2016;90:252-4.
    PubMed     Text format     Abstract available


  104. CHEN TK, Estrella MM
    APOL1 risk variants and death among African American hemodialysis patients: survival of the fittest?
    Kidney Int. 2016;90:249-52.
    PubMed     Text format     Abstract available


  105. RIGATTO C, Komenda P, Tangri N
    CABG or PCI: which is better for revascularization of coronary artery disease in chronic kidney disease?
    Kidney Int. 2016;90:257-9.
    PubMed     Text format     Abstract available


    July 2016
  106. SINGH S, Grabner A, Yanucil C, Schramm K, et al
    Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.
    Kidney Int. 2016 Jul 22. pii: S0085-2538(16)30236.
    PubMed     Text format     Abstract available


  107. CARLSEN RK, Peters CD, Khatir DS, Laugesen E, et al
    Estimated aortic blood pressure based on radial artery tonometry underestimates directly measured aortic blood pressure in patients with advancing chronic kidney disease staging and increasing arterial stiffness.
    Kidney Int. 2016 Jul 8. pii: S0085-2538(16)30205.
    PubMed     Text format     Abstract available


  108. HU YW
    Chinese herbal medicine use and risk of end-stage renal disease in patients with chronic kidney disease: is there an immortal time bias?
    Kidney Int. 2016;90:227-8.
    PubMed     Text format    


  109. WYATT CM, Cattran DC
    Intensive glycemic control and the risk of end-stage renal disease: an ADVANCE in the management of diabetes?
    Kidney Int. 2016;90:8-10.
    PubMed     Text format     Abstract available


  110. DE RECHTER S, Levtchenko E, Evenepoel P, Mekahli D, et al
    The Case | Hypercalcemia in a child with chronic kidney disease.
    Kidney Int. 2016;90:233-4.
    PubMed     Text format    


    June 2016
  111. WEIR MR, Bakris GL, Gross C, Mayo MR, et al
    Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Kidney Int. 2016 Jun 24. pii: S0085-2538(16)30186.
    PubMed     Text format     Abstract available


  112. HALLAN SI, Ovrehus MA, Romundstad S, Rifkin D, et al
    Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway.
    Kidney Int. 2016 Jun 22. pii: S0085-2538(16)30170.
    PubMed     Text format     Abstract available


  113. ZHOU Q, Bajo MA, Del Peso G, Yu X, et al
    Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
    Kidney Int. 2016 Jun 7. pii: S0085-2538(16)30138.
    PubMed     Text format     Abstract available


  114. BARBIERI C, Molina M, Ponce P, Tothova M, et al
    An international observational study suggests that artificial intelligence for clinical decision support optimizes anemia management in hemodialysis patients.
    Kidney Int. 2016 Jun 2. pii: S0085-2538(16)30132.
    PubMed     Text format     Abstract available


  115. CHEN T, Cleland B, Nankivell BJ
    The Case | Rapidly progressing polyneuropathy in a dialysis patient.
    Kidney Int. 2016;89:1409-10.
    PubMed     Text format    


  116. WHEELER DC, Kasiske BL
    Statins for hemodialysis patients with diabetes? Long-term follow-up endorses the original conclusions of the 4D Study.
    Kidney Int. 2016;89:1189-91.
    PubMed     Text format     Abstract available


  117. JESUDASON D, Clifton P
    Limitations of using the Chronic Kidney Disease-Epidemiology Collaboration equation for measuring renal function in obese populations.
    Kidney Int. 2016;89:1400-1.
    PubMed     Text format    


  118. HAGE V, Pelletier S, Fouque D
    No apparent link between serum Klotho and phosphate in human chronic kidney disease.
    Kidney Int. 2016;89:1399-400.
    PubMed     Text format    


  119. ENDRE ZH, Fernando M
    Unlocking the code: mining the urinary proteome after renal transplantation.
    Kidney Int. 2016;89:1183-5.
    PubMed     Text format     Abstract available


  120. MASSY ZA, Drueke TB
    Activin receptor IIA ligand trap in chronic kidney disease: 1 drug to prevent 2 complications-or even more?
    Kidney Int. 2016;89:1180-2.
    PubMed     Text format     Abstract available


  121. WYATT CM, Shineski M, Chertow GM, Bangalore S, et al
    ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials.
    Kidney Int. 2016;89:1178-9.
    PubMed     Text format     Abstract available


    May 2016
  122. CHARYTAN DM, Desai M, Mathur M, Stern NM, et al
    Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.
    Kidney Int. 2016 May 31. pii: S0085-2538(16)30126.
    PubMed     Text format     Abstract available


  123. ZHANG F, Masania J, Anwar A, Xue M, et al
    The uremic toxin oxythiamine causes functional thiamine deficiency in end-stage renal disease by inhibiting transketolase activity.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30057.
    PubMed     Text format     Abstract available


  124. MATHEW AT, Fishbane S, Obi Y, Kalantar-Zadeh K, et al
    Preservation of residual kidney function in hemodialysis patients: reviving an old concept.
    Kidney Int. 2016 May 12. pii: S0085-2538(16)30054.
    PubMed     Text format     Abstract available


  125. MARCELLI D, Bayh I, Merello JI, Ponce P, et al
    Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30056.
    PubMed     Text format     Abstract available


  126. ROMANOWSKI K, Clark EG, Levin A, Cook VJ, et al
    Tuberculosis and chronic kidney disease: an emerging global syndemic.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30053.
    PubMed     Text format     Abstract available


  127. SALAND JM, Satlin LM, Zalsos-Johnson J, Cremers S, et al
    Impaired postprandial lipemic response in chronic kidney disease.
    Kidney Int. 2016 May 7. pii: S0085-2538(16)30011.
    PubMed     Text format     Abstract available


  128. MA L, Langefeld CD, Comeau ME, Bonomo JA, et al
    APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Kidney Int. 2016 May 5. pii: S0085-2538(16)30012.
    PubMed     Text format     Abstract available


  129. CARRERO JJ, Johansen KL, Lindholm B, Stenvinkel P, et al
    Screening for muscle wasting and dysfunction in patients with chronic kidney disease.
    Kidney Int. 2016 May 5. pii: S0085-2538(16)30003.
    PubMed     Text format     Abstract available


    April 2016
  130. CHESNAYE NC, Schaefer F, Groothoff JW, Bonthuis M, et al
    Mortality risk in European children with end-stage renal disease on dialysis.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00366.
    PubMed     Text format     Abstract available


  131. NEU AM, Richardson T, Lawlor J, Stuart J, et al
    Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00365.
    PubMed     Text format     Abstract available


  132. BENGHANEM GHARBI M, Elseviers M, Zamd M, Belghiti Alaoui A, et al
    Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD.
    Kidney Int. 2016 Apr 13. pii: S0085-2538(16)00369.
    PubMed     Text format     Abstract available


  133. ZHANG L, Lee G, Liu X, Pascoe EM, et al
    Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Kidney Int. 2016 Apr 8. pii: S0085-2538(16)00363.
    PubMed     Text format     Abstract available


    March 2016
  134. CARRILLO-LOPEZ N, Panizo S, Alonso-Montes C, Roman-Garcia P, et al
    Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
    Kidney Int. 2016 Mar 24. pii: S0085-2538(16)00314.
    PubMed     Text format     Abstract available


  135. AGAPOVA OA, Fang Y, Sugatani T, Seifert ME, et al
    Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease.
    Kidney Int. 2016 Mar 11. pii: S0085-2538(16)00290.
    PubMed     Text format     Abstract available


  136. SIGDEL TK, Gao Y, He J, Wang A, et al
    Mining the human urine proteome for monitoring renal transplant injury.
    Kidney Int. 2016 Mar 4. pii: S0085-2538(16)00288.
    PubMed     Text format     Abstract available


    February 2016
  137. LEE T, Derebail VK, Kshirsagar AV, Chung Y, et al
    Patients with primary membranous nephropathy are at high risk of cardiovascular events.
    Kidney Int. 2016 Feb 26. pii: S0085-2538(16)00275.
    PubMed     Text format     Abstract available


  138. TAN BK, Yu Z, Fang W, Lin A, et al
    Longitudinal bioimpedance vector plots add little value to fluid management of peritoneal dialysis patients.
    Kidney Int. 2016;89:487-97.
    PubMed     Text format     Abstract available


  139. JING YJ, Ni JW, Ding FH, Fang YH, et al
    p-Cresyl sulfate is associated with carotid arteriosclerosis in hemodialysis patients and promotes atherogenesis in apoE-/- mice.
    Kidney Int. 2016;89:439-49.
    PubMed     Text format     Abstract available


    January 2016
  140. BARBOUR SJ, Espino-Hernandez G, Reich HN, Coppo R, et al
    The MEST score provides earlier risk prediction in lgA nephropathy.
    Kidney Int. 2016;89:167-75.
    PubMed     Text format     Abstract available


  141. SELAMET U, Tighiouart H, Sarnak MJ, Beck G, et al
    Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: The Modification of Diet in Renal Disease Study.
    Kidney Int. 2016;89:176-84.
    PubMed     Text format     Abstract available


  142. DAVENPORT A, Peters SA, Bots ML, Canaud B, et al
    Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body size.
    Kidney Int. 2016;89:193-9.
    PubMed     Text format     Abstract available


    July 2015
  143. RABASCO C, Cavero T, Roman E, Rojas-Rivera J, et al
    Effectiveness of mycophenolate mofetil in C3 glomerulonephritis.
    Kidney Int. 2015 Jul 29. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


  144. CAMPBELL SB, Clayton PA
    A scoring system to screen elderly potential kidney transplant recipients: a simple tool for a complex task.
    Kidney Int. 2015;88:5-6.
    PubMed     Text format     Abstract available


    June 2015
  145. BERTHELOT L, Robert T, Vuiblet V, Tabary T, et al
    Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Kidney Int. 2015 Jun 10. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


    May 2015
  146. SIM JJ, Bhandari SK, Shi J, Reynolds K, et al
    Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension.
    Kidney Int. 2015 May 6. doi: 10.1038/ki.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: